Pregabalin
NDC 50228-651, PREGABALIN, capsule, from ScieGen Pharmaceuticals, Inc.
- Product NDC
- 50228-651
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208677
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/50228-651 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PREGABALIN225 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-651-05 | 50228065105 | 500 CAPSULE in 1 BOTTLE (50228-651-05) |
| 50228-651-90 | 50228065190 | 90 CAPSULE in 1 BOTTLE (50228-651-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/459f0d31-a73f-2c62-e063-6394a90a810cNADAC price for package 50228065105
GET /v1/drugs/nadac/50228065105NADAC price for package 50228065190
GET /v1/drugs/nadac/50228065190
Use it
Look up 50228-651 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-651 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-651. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.